0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lomefloxacin Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-39H8236
Home | Market Reports | Health| Pharmacy
Global Lomefloxacin Market Insights Forecast to 2028
BUY CHAPTERS

Global Lomefloxacin Market Research Report 2025

Code: QYRE-Auto-39H8236
Report
July 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lomefloxacin Market

The global market for Lomefloxacin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Lomefloxacin is a fluoroquinolone anti-bacterial agent, used to treat bacterial infections including bronchitis and urinary tract infections (UTIs). This ingredient could inhibit bacterial DNA Rotase and have a high antibacterial activity against Enterobacteriaceae bacteria such as E.coli, S.pneumoniae, H.influenzae,S.aureus, P.aeruginosa and so on. Additionally, it has been employed for the prophylaxis of UTIs prior to surgery as well.
North American market for Lomefloxacin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lomefloxacin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Lomefloxacin in External is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Lomefloxacin include Pfizer, Nakoda Chemicals LTD, LGM Pharma, Merck, Norna Chemical, Changzhou Sinly Pharmchem, ParChem, Sichuan North Hongguang Special Chemical, IRISYS, Merck KGaA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lomefloxacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lomefloxacin.
The Lomefloxacin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lomefloxacin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lomefloxacin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lomefloxacin Market Report

Report Metric Details
Report Name Lomefloxacin Market
Segment by Type
  • Injection
  • Tablet
  • Capsule
  • Drops
  • Ointment
Segment by Application
  • External
  • Oral
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Nakoda Chemicals LTD, LGM Pharma, Merck, Norna Chemical, Changzhou Sinly Pharmchem, ParChem, Sichuan North Hongguang Special Chemical, IRISYS, Merck KGaA, Hangzhou Longshine Bio-Tech, Fengchen Group, Shanxi PUDE Pharmaceutical, Shanghai Harvest Pharmaceutical, Jiangsu Lianshui Pharmaceutical, Fuan Pharmaceutical, Changzhou Lanling Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Lomefloxacin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lomefloxacin Market report?

Ans: The main players in the Lomefloxacin Market are Pfizer, Nakoda Chemicals LTD, LGM Pharma, Merck, Norna Chemical, Changzhou Sinly Pharmchem, ParChem, Sichuan North Hongguang Special Chemical, IRISYS, Merck KGaA, Hangzhou Longshine Bio-Tech, Fengchen Group, Shanxi PUDE Pharmaceutical, Shanghai Harvest Pharmaceutical, Jiangsu Lianshui Pharmaceutical, Fuan Pharmaceutical, Changzhou Lanling Pharmaceutical

What are the Application segmentation covered in the Lomefloxacin Market report?

Ans: The Applications covered in the Lomefloxacin Market report are External, Oral

What are the Type segmentation covered in the Lomefloxacin Market report?

Ans: The Types covered in the Lomefloxacin Market report are Injection, Tablet, Capsule, Drops, Ointment

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lomefloxacin Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Tablet
1.2.4 Capsule
1.2.5 Drops
1.2.6 Ointment
1.3 Market by Application
1.3.1 Global Lomefloxacin Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 External
1.3.3 Oral
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lomefloxacin Market Perspective (2020-2031)
2.2 Global Lomefloxacin Growth Trends by Region
2.2.1 Global Lomefloxacin Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lomefloxacin Historic Market Size by Region (2020-2025)
2.2.3 Lomefloxacin Forecasted Market Size by Region (2026-2031)
2.3 Lomefloxacin Market Dynamics
2.3.1 Lomefloxacin Industry Trends
2.3.2 Lomefloxacin Market Drivers
2.3.3 Lomefloxacin Market Challenges
2.3.4 Lomefloxacin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lomefloxacin Players by Revenue
3.1.1 Global Top Lomefloxacin Players by Revenue (2020-2025)
3.1.2 Global Lomefloxacin Revenue Market Share by Players (2020-2025)
3.2 Global Lomefloxacin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lomefloxacin Revenue
3.4 Global Lomefloxacin Market Concentration Ratio
3.4.1 Global Lomefloxacin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lomefloxacin Revenue in 2024
3.5 Global Key Players of Lomefloxacin Head office and Area Served
3.6 Global Key Players of Lomefloxacin, Product and Application
3.7 Global Key Players of Lomefloxacin, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lomefloxacin Breakdown Data by Type
4.1 Global Lomefloxacin Historic Market Size by Type (2020-2025)
4.2 Global Lomefloxacin Forecasted Market Size by Type (2026-2031)
5 Lomefloxacin Breakdown Data by Application
5.1 Global Lomefloxacin Historic Market Size by Application (2020-2025)
5.2 Global Lomefloxacin Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lomefloxacin Market Size (2020-2031)
6.2 North America Lomefloxacin Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lomefloxacin Market Size by Country (2020-2025)
6.4 North America Lomefloxacin Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lomefloxacin Market Size (2020-2031)
7.2 Europe Lomefloxacin Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lomefloxacin Market Size by Country (2020-2025)
7.4 Europe Lomefloxacin Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lomefloxacin Market Size (2020-2031)
8.2 Asia-Pacific Lomefloxacin Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lomefloxacin Market Size by Region (2020-2025)
8.4 Asia-Pacific Lomefloxacin Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lomefloxacin Market Size (2020-2031)
9.2 Latin America Lomefloxacin Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lomefloxacin Market Size by Country (2020-2025)
9.4 Latin America Lomefloxacin Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lomefloxacin Market Size (2020-2031)
10.2 Middle East & Africa Lomefloxacin Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lomefloxacin Market Size by Country (2020-2025)
10.4 Middle East & Africa Lomefloxacin Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Lomefloxacin Introduction
11.1.4 Pfizer Revenue in Lomefloxacin Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Nakoda Chemicals LTD
11.2.1 Nakoda Chemicals LTD Company Details
11.2.2 Nakoda Chemicals LTD Business Overview
11.2.3 Nakoda Chemicals LTD Lomefloxacin Introduction
11.2.4 Nakoda Chemicals LTD Revenue in Lomefloxacin Business (2020-2025)
11.2.5 Nakoda Chemicals LTD Recent Development
11.3 LGM Pharma
11.3.1 LGM Pharma Company Details
11.3.2 LGM Pharma Business Overview
11.3.3 LGM Pharma Lomefloxacin Introduction
11.3.4 LGM Pharma Revenue in Lomefloxacin Business (2020-2025)
11.3.5 LGM Pharma Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Lomefloxacin Introduction
11.4.4 Merck Revenue in Lomefloxacin Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Norna Chemical
11.5.1 Norna Chemical Company Details
11.5.2 Norna Chemical Business Overview
11.5.3 Norna Chemical Lomefloxacin Introduction
11.5.4 Norna Chemical Revenue in Lomefloxacin Business (2020-2025)
11.5.5 Norna Chemical Recent Development
11.6 Changzhou Sinly Pharmchem
11.6.1 Changzhou Sinly Pharmchem Company Details
11.6.2 Changzhou Sinly Pharmchem Business Overview
11.6.3 Changzhou Sinly Pharmchem Lomefloxacin Introduction
11.6.4 Changzhou Sinly Pharmchem Revenue in Lomefloxacin Business (2020-2025)
11.6.5 Changzhou Sinly Pharmchem Recent Development
11.7 ParChem
11.7.1 ParChem Company Details
11.7.2 ParChem Business Overview
11.7.3 ParChem Lomefloxacin Introduction
11.7.4 ParChem Revenue in Lomefloxacin Business (2020-2025)
11.7.5 ParChem Recent Development
11.8 Sichuan North Hongguang Special Chemical
11.8.1 Sichuan North Hongguang Special Chemical Company Details
11.8.2 Sichuan North Hongguang Special Chemical Business Overview
11.8.3 Sichuan North Hongguang Special Chemical Lomefloxacin Introduction
11.8.4 Sichuan North Hongguang Special Chemical Revenue in Lomefloxacin Business (2020-2025)
11.8.5 Sichuan North Hongguang Special Chemical Recent Development
11.9 IRISYS
11.9.1 IRISYS Company Details
11.9.2 IRISYS Business Overview
11.9.3 IRISYS Lomefloxacin Introduction
11.9.4 IRISYS Revenue in Lomefloxacin Business (2020-2025)
11.9.5 IRISYS Recent Development
11.10 Merck KGaA
11.10.1 Merck KGaA Company Details
11.10.2 Merck KGaA Business Overview
11.10.3 Merck KGaA Lomefloxacin Introduction
11.10.4 Merck KGaA Revenue in Lomefloxacin Business (2020-2025)
11.10.5 Merck KGaA Recent Development
11.11 Hangzhou Longshine Bio-Tech
11.11.1 Hangzhou Longshine Bio-Tech Company Details
11.11.2 Hangzhou Longshine Bio-Tech Business Overview
11.11.3 Hangzhou Longshine Bio-Tech Lomefloxacin Introduction
11.11.4 Hangzhou Longshine Bio-Tech Revenue in Lomefloxacin Business (2020-2025)
11.11.5 Hangzhou Longshine Bio-Tech Recent Development
11.12 Fengchen Group
11.12.1 Fengchen Group Company Details
11.12.2 Fengchen Group Business Overview
11.12.3 Fengchen Group Lomefloxacin Introduction
11.12.4 Fengchen Group Revenue in Lomefloxacin Business (2020-2025)
11.12.5 Fengchen Group Recent Development
11.13 Shanxi PUDE Pharmaceutical
11.13.1 Shanxi PUDE Pharmaceutical Company Details
11.13.2 Shanxi PUDE Pharmaceutical Business Overview
11.13.3 Shanxi PUDE Pharmaceutical Lomefloxacin Introduction
11.13.4 Shanxi PUDE Pharmaceutical Revenue in Lomefloxacin Business (2020-2025)
11.13.5 Shanxi PUDE Pharmaceutical Recent Development
11.14 Shanghai Harvest Pharmaceutical
11.14.1 Shanghai Harvest Pharmaceutical Company Details
11.14.2 Shanghai Harvest Pharmaceutical Business Overview
11.14.3 Shanghai Harvest Pharmaceutical Lomefloxacin Introduction
11.14.4 Shanghai Harvest Pharmaceutical Revenue in Lomefloxacin Business (2020-2025)
11.14.5 Shanghai Harvest Pharmaceutical Recent Development
11.15 Jiangsu Lianshui Pharmaceutical
11.15.1 Jiangsu Lianshui Pharmaceutical Company Details
11.15.2 Jiangsu Lianshui Pharmaceutical Business Overview
11.15.3 Jiangsu Lianshui Pharmaceutical Lomefloxacin Introduction
11.15.4 Jiangsu Lianshui Pharmaceutical Revenue in Lomefloxacin Business (2020-2025)
11.15.5 Jiangsu Lianshui Pharmaceutical Recent Development
11.16 Fuan Pharmaceutical
11.16.1 Fuan Pharmaceutical Company Details
11.16.2 Fuan Pharmaceutical Business Overview
11.16.3 Fuan Pharmaceutical Lomefloxacin Introduction
11.16.4 Fuan Pharmaceutical Revenue in Lomefloxacin Business (2020-2025)
11.16.5 Fuan Pharmaceutical Recent Development
11.17 Changzhou Lanling Pharmaceutical
11.17.1 Changzhou Lanling Pharmaceutical Company Details
11.17.2 Changzhou Lanling Pharmaceutical Business Overview
11.17.3 Changzhou Lanling Pharmaceutical Lomefloxacin Introduction
11.17.4 Changzhou Lanling Pharmaceutical Revenue in Lomefloxacin Business (2020-2025)
11.17.5 Changzhou Lanling Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Lomefloxacin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Injection
 Table 3. Key Players of Tablet
 Table 4. Key Players of Capsule
 Table 5. Key Players of Drops
 Table 6. Key Players of Ointment
 Table 7. Global Lomefloxacin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Lomefloxacin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Lomefloxacin Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Lomefloxacin Market Share by Region (2020-2025)
 Table 11. Global Lomefloxacin Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Lomefloxacin Market Share by Region (2026-2031)
 Table 13. Lomefloxacin Market Trends
 Table 14. Lomefloxacin Market Drivers
 Table 15. Lomefloxacin Market Challenges
 Table 16. Lomefloxacin Market Restraints
 Table 17. Global Lomefloxacin Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Lomefloxacin Market Share by Players (2020-2025)
 Table 19. Global Top Lomefloxacin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lomefloxacin as of 2024)
 Table 20. Ranking of Global Top Lomefloxacin Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Lomefloxacin Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Lomefloxacin, Headquarters and Area Served
 Table 23. Global Key Players of Lomefloxacin, Product and Application
 Table 24. Global Key Players of Lomefloxacin, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Lomefloxacin Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Lomefloxacin Revenue Market Share by Type (2020-2025)
 Table 28. Global Lomefloxacin Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Lomefloxacin Revenue Market Share by Type (2026-2031)
 Table 30. Global Lomefloxacin Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Lomefloxacin Revenue Market Share by Application (2020-2025)
 Table 32. Global Lomefloxacin Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Lomefloxacin Revenue Market Share by Application (2026-2031)
 Table 34. North America Lomefloxacin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Lomefloxacin Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Lomefloxacin Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Lomefloxacin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Lomefloxacin Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Lomefloxacin Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Lomefloxacin Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Lomefloxacin Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Lomefloxacin Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Lomefloxacin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Lomefloxacin Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Lomefloxacin Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Lomefloxacin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Lomefloxacin Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Lomefloxacin Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Pfizer Company Details
 Table 50. Pfizer Business Overview
 Table 51. Pfizer Lomefloxacin Product
 Table 52. Pfizer Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 53. Pfizer Recent Development
 Table 54. Nakoda Chemicals LTD Company Details
 Table 55. Nakoda Chemicals LTD Business Overview
 Table 56. Nakoda Chemicals LTD Lomefloxacin Product
 Table 57. Nakoda Chemicals LTD Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 58. Nakoda Chemicals LTD Recent Development
 Table 59. LGM Pharma Company Details
 Table 60. LGM Pharma Business Overview
 Table 61. LGM Pharma Lomefloxacin Product
 Table 62. LGM Pharma Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 63. LGM Pharma Recent Development
 Table 64. Merck Company Details
 Table 65. Merck Business Overview
 Table 66. Merck Lomefloxacin Product
 Table 67. Merck Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 68. Merck Recent Development
 Table 69. Norna Chemical Company Details
 Table 70. Norna Chemical Business Overview
 Table 71. Norna Chemical Lomefloxacin Product
 Table 72. Norna Chemical Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 73. Norna Chemical Recent Development
 Table 74. Changzhou Sinly Pharmchem Company Details
 Table 75. Changzhou Sinly Pharmchem Business Overview
 Table 76. Changzhou Sinly Pharmchem Lomefloxacin Product
 Table 77. Changzhou Sinly Pharmchem Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 78. Changzhou Sinly Pharmchem Recent Development
 Table 79. ParChem Company Details
 Table 80. ParChem Business Overview
 Table 81. ParChem Lomefloxacin Product
 Table 82. ParChem Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 83. ParChem Recent Development
 Table 84. Sichuan North Hongguang Special Chemical Company Details
 Table 85. Sichuan North Hongguang Special Chemical Business Overview
 Table 86. Sichuan North Hongguang Special Chemical Lomefloxacin Product
 Table 87. Sichuan North Hongguang Special Chemical Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 88. Sichuan North Hongguang Special Chemical Recent Development
 Table 89. IRISYS Company Details
 Table 90. IRISYS Business Overview
 Table 91. IRISYS Lomefloxacin Product
 Table 92. IRISYS Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 93. IRISYS Recent Development
 Table 94. Merck KGaA Company Details
 Table 95. Merck KGaA Business Overview
 Table 96. Merck KGaA Lomefloxacin Product
 Table 97. Merck KGaA Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 98. Merck KGaA Recent Development
 Table 99. Hangzhou Longshine Bio-Tech Company Details
 Table 100. Hangzhou Longshine Bio-Tech Business Overview
 Table 101. Hangzhou Longshine Bio-Tech Lomefloxacin Product
 Table 102. Hangzhou Longshine Bio-Tech Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 103. Hangzhou Longshine Bio-Tech Recent Development
 Table 104. Fengchen Group Company Details
 Table 105. Fengchen Group Business Overview
 Table 106. Fengchen Group Lomefloxacin Product
 Table 107. Fengchen Group Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 108. Fengchen Group Recent Development
 Table 109. Shanxi PUDE Pharmaceutical Company Details
 Table 110. Shanxi PUDE Pharmaceutical Business Overview
 Table 111. Shanxi PUDE Pharmaceutical Lomefloxacin Product
 Table 112. Shanxi PUDE Pharmaceutical Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 113. Shanxi PUDE Pharmaceutical Recent Development
 Table 114. Shanghai Harvest Pharmaceutical Company Details
 Table 115. Shanghai Harvest Pharmaceutical Business Overview
 Table 116. Shanghai Harvest Pharmaceutical Lomefloxacin Product
 Table 117. Shanghai Harvest Pharmaceutical Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 118. Shanghai Harvest Pharmaceutical Recent Development
 Table 119. Jiangsu Lianshui Pharmaceutical Company Details
 Table 120. Jiangsu Lianshui Pharmaceutical Business Overview
 Table 121. Jiangsu Lianshui Pharmaceutical Lomefloxacin Product
 Table 122. Jiangsu Lianshui Pharmaceutical Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 123. Jiangsu Lianshui Pharmaceutical Recent Development
 Table 124. Fuan Pharmaceutical Company Details
 Table 125. Fuan Pharmaceutical Business Overview
 Table 126. Fuan Pharmaceutical Lomefloxacin Product
 Table 127. Fuan Pharmaceutical Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 128. Fuan Pharmaceutical Recent Development
 Table 129. Changzhou Lanling Pharmaceutical Company Details
 Table 130. Changzhou Lanling Pharmaceutical Business Overview
 Table 131. Changzhou Lanling Pharmaceutical Lomefloxacin Product
 Table 132. Changzhou Lanling Pharmaceutical Revenue in Lomefloxacin Business (2020-2025) & (US$ Million)
 Table 133. Changzhou Lanling Pharmaceutical Recent Development
 Table 134. Research Programs/Design for This Report
 Table 135. Key Data Information from Secondary Sources
 Table 136. Key Data Information from Primary Sources
 Table 137. Authors List of This Report


List of Figures
 Figure 1. Lomefloxacin Picture
 Figure 2. Global Lomefloxacin Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lomefloxacin Market Share by Type: 2024 VS 2031
 Figure 4. Injection Features
 Figure 5. Tablet Features
 Figure 6. Capsule Features
 Figure 7. Drops Features
 Figure 8. Ointment Features
 Figure 9. Global Lomefloxacin Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Lomefloxacin Market Share by Application: 2024 VS 2031
 Figure 11. External Case Studies
 Figure 12. Oral Case Studies
 Figure 13. Lomefloxacin Report Years Considered
 Figure 14. Global Lomefloxacin Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Lomefloxacin Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Lomefloxacin Market Share by Region: 2024 VS 2031
 Figure 17. Global Lomefloxacin Market Share by Players in 2024
 Figure 18. Global Top Lomefloxacin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lomefloxacin as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Lomefloxacin Revenue in 2024
 Figure 20. North America Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Lomefloxacin Market Share by Country (2020-2031)
 Figure 22. United States Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Lomefloxacin Market Share by Country (2020-2031)
 Figure 26. Germany Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Lomefloxacin Market Share by Region (2020-2031)
 Figure 34. China Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Lomefloxacin Market Share by Country (2020-2031)
 Figure 42. Mexico Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Lomefloxacin Market Share by Country (2020-2031)
 Figure 46. Turkey Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Lomefloxacin Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Pfizer Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 50. Nakoda Chemicals LTD Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 51. LGM Pharma Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 52. Merck Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 53. Norna Chemical Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 54. Changzhou Sinly Pharmchem Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 55. ParChem Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 56. Sichuan North Hongguang Special Chemical Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 57. IRISYS Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 58. Merck KGaA Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 59. Hangzhou Longshine Bio-Tech Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 60. Fengchen Group Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 61. Shanxi PUDE Pharmaceutical Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 62. Shanghai Harvest Pharmaceutical Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 63. Jiangsu Lianshui Pharmaceutical Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 64. Fuan Pharmaceutical Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 65. Changzhou Lanling Pharmaceutical Revenue Growth Rate in Lomefloxacin Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart